Associations of patients with different centrosome index (CI)
. | CI above 4, no./no. total (%) . | CI below 4, no./no. total (%) . | P . |
|---|---|---|---|
| Relapse cases | 7/26 (27) | 21/71 (27) | .80 |
| Hyperdiploid cases | 12/25 (48) | 43/71 (61) | .25 |
| Δ13 | 17/26 (65) | 27/70 (38) | .02 |
| TC classes | |||
| 4p16 + MAF | 6/26 (23) | 4/71 (6) | .02 |
| 11q13 + 6p21 | 6/26 (23) | 10/71 (14) | .36 |
| D1 + (D1 + D2) | 8/26 (31) | 40/71 (56) | .04 |
| D2 + None | 6/26 (23) | 17/71 (24) | > .999 |
| PCLI greater than 1 | 18/26 (69) | 19/71 (27) | < .001 |
| ISS stage | |||
| I | 7/19 (37) | 23/59 (39) | > .999 |
| II | 6/19 (32) | 23/59 (39) | .60 |
| III | 6/19 (32) | 13/59 (22) | .54 |
. | CI above 4, no./no. total (%) . | CI below 4, no./no. total (%) . | P . |
|---|---|---|---|
| Relapse cases | 7/26 (27) | 21/71 (27) | .80 |
| Hyperdiploid cases | 12/25 (48) | 43/71 (61) | .25 |
| Δ13 | 17/26 (65) | 27/70 (38) | .02 |
| TC classes | |||
| 4p16 + MAF | 6/26 (23) | 4/71 (6) | .02 |
| 11q13 + 6p21 | 6/26 (23) | 10/71 (14) | .36 |
| D1 + (D1 + D2) | 8/26 (31) | 40/71 (56) | .04 |
| D2 + None | 6/26 (23) | 17/71 (24) | > .999 |
| PCLI greater than 1 | 18/26 (69) | 19/71 (27) | < .001 |
| ISS stage | |||
| I | 7/19 (37) | 23/59 (39) | > .999 |
| II | 6/19 (32) | 23/59 (39) | .60 |
| III | 6/19 (32) | 13/59 (22) | .54 |